TRAW — Traws Pharma Balance Sheet
0.000.00%
- $22.57m
- $19.44m
- $2.79m
Annual balance sheet for Traws Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 55.1 | 38.8 | 20.8 | 21.3 | 3.82 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.028 | 0.029 | 0.018 | 1.76 | 3.79 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 55.4 | 39.3 | 22.7 | 25 | 7.98 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.038 | 0.024 | 0.022 | 0.01 | 0.007 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 55.5 | 39.4 | 22.7 | 25 | 10.6 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6.12 | 8.05 | 9.22 | 11.5 | 11.1 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 9.36 | 11.1 | 12 | 56.6 | 11.2 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 46.1 | 28.3 | 10.7 | -31.6 | -0.629 |
| Total Liabilities & Shareholders' Equity | 55.5 | 39.4 | 22.7 | 25 | 10.6 |
| Total Common Shares Outstanding |